STXS Stock - Stereotaxis Inc.

STXS Stock Chart

STXS Profile

Stereotaxis, Inc., based in Saint Louis, Missouri, is a pioneering developer, manufacturer, and marketer of advanced robotic systems, instruments, and information solutions designed for interventional cardiology and electrophysiology procedures worldwide. The company's flagship offerings include robotic magnetic navigation (RMN) systems like the Genesis RMN and Niobe systems, which enable precise, image-guided navigation of catheters and guidewires through the intricate blood vessels and chambers of the heart, facilitating complex interventional procedures with enhanced accuracy and efficiency.

Complementing its RMN systems, Stereotaxis provides the Odyssey platform, a comprehensive real-time information solution that manages, records, and shares procedural data seamlessly across networks. The company also offers the Stereotaxis Imaging Model S X-ray system, featuring advanced imaging capabilities essential for robotic interventional operating rooms, equipped with high-definition monitors and motorized equipment for optimal procedural outcomes.

In addition to its hardware solutions, Stereotaxis supplies a range of disposables and accessories such as QuikCAS automated catheter advancement disposables and various diagnostic/ablation steerable tip catheters like CARTO RMT and NAVISTAR RMT series. The company's Vdrive system enhances procedural navigation and stability for diagnostic and therapeutic devices, improving overall interventional precision.

Founded in 1990, Stereotaxis continues to innovate through strategic collaborations, including a notable partnership with Osypka AG to develop magnetic ablation catheters leveraging Stereotaxis' robotic technology. With a global presence facilitated by direct sales, distributors, and sales agents, Stereotaxis remains committed to advancing medical technology to empower healthcare providers in delivering superior patient care in the field of interventional cardiology and electrophysiology.

STXS Revenue Chart

STXS Earnings

Analyst Ratings